Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic profiling of UV damage repair patches uncovers histone chaperones with central functions in chromatin repair. | Nat Commun | 2026 | 41605964 | PubTator, text mining | PubMed |
| Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma. | Discov Oncol | 2026 | 41604018 | PubTator, text mining | PubMed |
| <p>CDK1 depletion suppresses glioma malignancy through cell cycle pathway regulation: Mechanistic insights from functional and molecular profiling</p>. | Oncol Rep | 2026 | 41543195 | PubTator, text mining | PubMed |
| Single-cell profiling defines the cellular landscape of the urinary bladder: a scoping review. | Eur J Med Res | 2026 | 41491261 | PubTator, text mining | PubMed |
| Proximal proteomics analysis reveals DNA polymerase δ subunit 3 is a new MCM2 binding partner and promotes parental histones inheritance in mammalian cells. | Cell Death Differ | 2026 | 41310184 | PubTator, text mining | PubMed |
| Validation of an immunohistochemistry-based molecular group stratification of intracranial meningiomas. | J Neuropathol Exp Neurol | 2026 | 41093285 | PubTator, text mining | PubMed |
| Utilization of DNA Replication factor MCM2 by Cancer. | Curr Cancer Drug Targets | 2026 | 39949096 | PubTator, text mining | PubMed |
| Exploratory research on therapeutic agents combined with early diagnostic biomarkers for colorectal cancer. | Front Pharmacol | 2025 | 41585903 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Associated with the Development of Cervical Cancer. | Int J Mol Sci | 2025 | 41516135 | PubTator, text mining | PubMed |
| Decoding protein dynamics with limited proteolysis coupled to mass spectrometry: A comprehensive review. | J Pharm Anal | 2025 | 41487146 | PubTator, text mining | PubMed |
| Geminin inhibits DNA replication licensing by sterically blocking CDT1-MCM2 interactions. | Nat Commun | 2025 | 41365879 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis and Experimental Validation of the Role of Cellular Senescence in Osteoporosis. | Calcif Tissue Int | 2025 | 41361583 | PubTator, text mining | PubMed |
| Protein kinase D2-mediated maintenance complex component 2 phosphorylation promotes bladder cancer progression. | J Transl Med | 2025 | 41299687 | PubTator, text mining | PubMed |
| High ORC6 expression is a prognostic indicator of poor survival in glioma patients. | Sci Rep | 2025 | 41258386 | PubTator, text mining | PubMed |
| PCNA and MCM 2 in Odontogenic Tumors: An Immunnohistological Study. | J Pharm Bioallied Sci | 2025 | 41164593 | PubTator, text mining | PubMed |
| CRL4DCAF12 regulation of MCMBP ensures optimal licensing of DNA replication. | Nat Commun | 2025 | 41145411 | PubTator, text mining | PubMed |
| Decoding Cervical Cancer Biomarkers: An Integrated Framework of Bioinformatics, Machine Learning, and Experimental Confirmation. | Cancer Invest | 2025 | 41123057 | PubTator, text mining | PubMed |
| Identifying TP53RK as a key regulator of colorectal cancer survival and a potential therapeutic target. | Sci Rep | 2025 | 41102525 | PubTator, text mining | PubMed |
| Molecular insights into proliferation and inflammation in actinic keratosis and photodynamic therapy: a comprehensive review of proliferation and inflammation markers. | Contemp Oncol (Pozn) | 2025 | 41098866 | PubTator, text mining | PubMed |
| Antagonistic histone post-translational modifications improve the fidelity of epigenetic inheritance - a Bayesian perspective. | Epigenetics Chromatin | 2025 | 41074147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=3